TACTILE SYSTEMS TECHNOLOGY INC (TCMD)

Latest Insider Confidence Score

2026Q1

51.9
Bullish

Company insider confidence (by quarter)

2016Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Shroff Zubeen — 4,805,691 May 11, 2017
Galen Partners V LP 10% Owner 907,736 Sep 19, 2017
Galen Partners International V LP 10% Owner 907,736 Sep 19, 2017
Galen Management, LLC 10% Owner 907,736 Sep 19, 2017
Galen Partners V, L.L.C. 10% Owner 907,736 Sep 19, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 24, 2026 Feb 26, 2026 Dodd Sheri Louise CEO Sell 20.0 -10,993 -4.31% ✗ $318.1K
Feb 24, 2026 Feb 26, 2026 Birkemeyer Elaine M. CFO Sell 22.5 -7,701 -5.40% ✗ $222.9K
Feb 24, 2026 Feb 26, 2026 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 22.5 -6,246 -7.03% ✗ $180.8K
Feb 20, 2026 Feb 24, 2026 Birkemeyer Elaine M. CFO Sell 95.0 +20,401 16.71% ✗ $156.1K
Feb 20, 2026 Feb 24, 2026 Dodd Sheri Louise CEO Sell 97.5 +32,727 14.73% ✗ $431.2K
Feb 20, 2026 Feb 24, 2026 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 95.0 +10,232 13.02% ✗ $125.6K
Feb 19, 2026 Feb 23, 2026 Dodd Sheri Louise CEO Neutral 90.0 +48,672 28.06% ✗ -
Feb 19, 2026 Feb 23, 2026 Burns Kristie Sr. VP Mktg & Clinical Affairs Neutral 85.0 +6,194 8.56% ✗ -
Feb 19, 2026 Feb 23, 2026 Birkemeyer Elaine M. CFO Neutral 90.0 +23,008 23.21% ✗ -
Jan 2, 2026 Jan 6, 2026 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 33.8 -5,139 -6.63% ✓ $148.3K
Aug 8, 2025 Aug 12, 2025 Dodd Sheri Louise CEO Sell 22.5 -7,762 -4.28% ✗ $95.9K
May 12, 2025 May 14, 2025 Birkemeyer Elaine M. CFO Sell 45.0 -2,921 -2.86% ✓ $29K
May 8, 2025 May 12, 2025 Dodd Sheri Louise CEO Sell 26.3 -3,149 -1.71% ✗ $31K
May 7, 2025 May 9, 2025 BURKE WILLIAM W Director Sell 91.3 +12,778 35.75% ✓ $31.9K
May 7, 2025 May 9, 2025 Asbury Valerie L. Director Neutral 90.0 +16,078 49.10% ✗ -
May 7, 2025 May 9, 2025 Huggenberger Raymond Director Neutral 90.0 +16,078 39.95% ✗ -
May 7, 2025 May 9, 2025 King Laura G. Director Neutral 90.0 +16,078 541.35% ✗ -
May 7, 2025 May 9, 2025 Shafer David Brent Director Neutral 90.0 +16,078 49.10% ✗ -
May 7, 2025 May 9, 2025 Volkart Carmen B Director Neutral 90.0 +16,078 74.37% ✗ -
May 7, 2025 May 9, 2025 Washington Boyd Vindell Director Neutral 90.0 +16,078 83.88% ✗ -
Mar 11, 2025 Mar 13, 2025 REUVERS DANIEL L. Director Neutral 52.5 - 0.00% ✗ -
Feb 25, 2025 Feb 27, 2025 Birkemeyer Elaine M. CFO Sell 48.8 -2,066 -1.98% ✓ $30K
Feb 25, 2025 Feb 27, 2025 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 22.5 -6,468 -7.70% ✗ $93.2K
Feb 25, 2025 Feb 27, 2025 REUVERS DANIEL L. Director Sell 22.5 -28,338 -11.66% ✓ $401.8K
Feb 20, 2025 Feb 24, 2025 REUVERS DANIEL L. Director Sell 82.5 +4,915 2.06% ✓ $159.1K
Feb 20, 2025 Feb 24, 2025 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 95.0 +19,239 29.70% ✗ $70.8K
Feb 20, 2025 Feb 24, 2025 Birkemeyer Elaine M. CFO Sell 95.0 +42,803 69.83% ✓ $55.5K
Feb 20, 2025 Feb 24, 2025 King Laura G. Director Neutral 90.0 +2,970 100.00% ✗ -
Feb 20, 2025 Feb 24, 2025 Dodd Sheri Louise CEO Neutral 90.0 +85,777 86.98% ✗ -
Jan 14, 2025 King Laura G. Director Neutral 52.5 - 0.00% ✗ -
Aug 12, 2024 Aug 14, 2024 Ferstler Sherri Lee Senior VP, Sales Sell 26.3 -1,550 -3.84% ✗ $20.3K
Aug 7, 2024 Aug 9, 2024 Dodd Sheri Louise CEO Neutral 90.0 +64,959 193.02% ✗ -
May 16, 2024 May 20, 2024 Birkemeyer Elaine M. CFO Sell 26.3 -3,041 -4.73% ✗ $41.6K
May 8, 2024 May 10, 2024 BURKE WILLIAM W Director Sell 91.3 +7,969 28.69% ✓ $35.2K
May 8, 2024 May 10, 2024 Asbury Valerie L. Director Neutral 90.0 +10,469 47.00% ✗ -
May 8, 2024 May 10, 2024 Dodd Sheri Louise Director Neutral 90.0 +10,469 45.15% ✗ -
May 8, 2024 May 10, 2024 Huggenberger Raymond Director Neutral 90.0 +10,469 35.16% ✗ -
May 8, 2024 May 10, 2024 Shafer David Brent Director Neutral 90.0 +10,469 47.00% ✗ -
May 8, 2024 May 10, 2024 Volkart Carmen B Director Neutral 90.0 +10,469 93.88% ✗ -
May 8, 2024 May 10, 2024 Washington Boyd Vindell Director Neutral 90.0 +10,469 120.33% ✗ -
May 6, 2024 May 8, 2024 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 26.3 -815 -1.29% ✗ $11.7K
Feb 27, 2024 Feb 29, 2024 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 45.0 -1,334 -2.06% ✓ $20.7K
Feb 27, 2024 Feb 29, 2024 REUVERS DANIEL L. CEO Sell 41.3 -6,085 -2.49% ✓ $94.4K
Feb 23, 2024 Feb 27, 2024 REUVERS DANIEL L. CEO Sell 95.0 +46,413 23.48% ✓ $178.5K
Feb 23, 2024 Feb 27, 2024 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 95.0 +7,498 13.39% ✓ $65.3K
Feb 24, 2024 Feb 27, 2024 Birkemeyer Elaine M. CFO Neutral 82.5 +2,848 4.63% ✗ -
Feb 21, 2024 Feb 23, 2024 REUVERS DANIEL L. CEO Neutral 90.0 +72,046 57.34% ✗ -
Feb 21, 2024 Feb 23, 2024 Burns Kristie Sr. VP Mktg & Clinical Affairs Neutral 90.0 +19,452 53.20% ✗ -
Feb 21, 2024 Feb 23, 2024 Ferstler Sherri Lee Senior VP, Sales Neutral 90.0 +21,613 115.57% ✗ -
Feb 21, 2024 Feb 23, 2024 Birkemeyer Elaine M. CFO Neutral 90.0 +32,420 111.53% ✗ -
Nov 8, 2023 Nov 13, 2023 Washington Boyd Vindell Director Neutral 90.0 +8,700 100.00% ✗ -
Oct 3, 2023 Washington Boyd Vindell Director Neutral 52.5 - 0.00% ✗ -
Aug 9, 2023 Aug 11, 2023 Ferstler Sherri Lee Senior VP, Sales Neutral 90.0 +18,701 100.00% ✗ -
Aug 7, 2023 Aug 9, 2023 REUVERS DANIEL L. CEO Sell 36.3 -1,062 -0.84% ✗ $21.8K
Aug 3, 2023 Ferstler Sherri Lee Senior VP, Sales Neutral 52.5 - 0.00% ✗ -
May 12, 2023 May 16, 2023 BURKE WILLIAM W Director Sell 25.0 -4,400 -13.68% ✓ $96.2K
May 10, 2023 May 11, 2023 Birkemeyer Elaine M. CFO Neutral 90.0 +29,068 100.00% ✗ -
May 8, 2023 May 10, 2023 Asbury Valerie L. Director Neutral 90.0 +7,737 53.22% ✗ -
May 8, 2023 May 10, 2023 BURKE WILLIAM W Director Neutral 90.0 +7,737 31.66% ✗ -
May 8, 2023 May 10, 2023 Dodd Sheri Louise Director Neutral 90.0 +7,737 50.08% ✗ -
May 8, 2023 May 10, 2023 Huggenberger Raymond Director Neutral 90.0 +7,737 35.11% ✗ -
May 8, 2023 May 10, 2023 Shafer David Brent Director Neutral 90.0 +7,737 53.22% ✗ -
May 8, 2023 May 10, 2023 Volkart Carmen B Director Neutral 90.0 +7,737 226.63% ✗ -
May 8, 2023 May 10, 2023 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 45.0 -786 -2.10% ✓ $14.7K
May 8, 2023 May 10, 2023 PAULS ERIC Senior VP, Sales Sell 48.8 -550 -1.83% ✓ $10.2K
Mar 22, 2023 Birkemeyer Elaine M. CFO Neutral 52.5 - 0.00% ✗ -
Mar 1, 2023 Mar 3, 2023 Moen Brent CFO Sell 26.3 -1,391 -2.77% ✗ $19.6K
Feb 25, 2023 Feb 28, 2023 REUVERS DANIEL L. CEO Sell 40.0 -605 -0.48% ✗ $107.7K
Feb 25, 2023 Feb 28, 2023 Moen Brent CFO Sell 22.5 -1,748 -3.37% ✗ $62.1K
Feb 25, 2023 Feb 28, 2023 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 26.3 -1,335 -3.45% ✗ $35.2K
Feb 25, 2023 Feb 28, 2023 PAULS ERIC Senior VP, Sales Sell 26.3 -878 -2.84% ✗ $22.5K
Feb 22, 2023 Feb 24, 2023 Volkart Carmen B Director Neutral 90.0 +3,414 100.00% ✗ -
Feb 22, 2023 Feb 24, 2023 REUVERS DANIEL L. CEO Neutral 90.0 +52,613 70.43% ✗ -
Feb 22, 2023 Feb 24, 2023 Burns Kristie Sr. VP Mktg & Clinical Affairs Neutral 90.0 +16,724 76.16% ✗ -
Feb 22, 2023 Feb 24, 2023 PAULS ERIC Senior VP, Sales Neutral 90.0 +12,627 69.00% ✗ -
Jan 5, 2023 Volkart Carmen B Director Neutral 52.5 - 0.00% ✗ -
Aug 8, 2022 Aug 10, 2022 REUVERS DANIEL L. CEO Sell 27.5 -1,020 -1.35% ✗ $9.4K
Aug 4, 2022 Aug 8, 2022 BURKE WILLIAM W Director Buy 91.3 +4,900 25.08% ✗ $44.8K
May 19, 2022 May 23, 2022 BURKE WILLIAM W Director Sell 36.3 -1,100 -5.33% ✓ $11.1K
May 9, 2022 May 11, 2022 Asbury Valerie L. Director Neutral 90.0 +12,103 497.04% ✗ -
May 9, 2022 May 11, 2022 Shafer David Brent Director Neutral 90.0 +12,103 497.04% ✗ -
May 9, 2022 May 11, 2022 BURKE WILLIAM W Director Neutral 90.0 +12,103 141.84% ✗ -
May 9, 2022 May 11, 2022 Dodd Sheri Louise Director Neutral 90.0 +12,103 361.82% ✗ -
May 9, 2022 May 11, 2022 Jain Deepti Director Neutral 90.0 +12,103 361.82% ✗ -
May 9, 2022 May 11, 2022 Huggenberger Raymond Director Neutral 90.0 +12,103 121.85% ✗ -
May 6, 2022 May 10, 2022 Burns Kristie Sr. VP Mktg & Clinical Affairs Sell 41.3 -999 -4.35% ✓ $13K
May 6, 2022 May 10, 2022 PAULS ERIC Senior VP, Sales Sell 27.5 -600 -3.17% ✗ $7.8K
Mar 7, 2022 Mar 9, 2022 Moen Brent CFO Sell 53.8 -176 -0.34% ✓ $3.6K
Mar 1, 2022 Mar 3, 2022 Moen Brent CFO Sell 26.3 -1,632 -3.04% ✗ $33.2K
Feb 24, 2022 Feb 28, 2022 REUVERS DANIEL L. CEO Sell 91.3 +53,060 234.08% ✗ $17.4K
Feb 24, 2022 Feb 28, 2022 Moen Brent CFO Sell 91.3 +28,502 113.08% ✗ $12.4K
Feb 24, 2022 Feb 28, 2022 Burns Kristie Sr. VP Mktg & Clinical Affairs Neutral 90.0 +16,181 238.76% ✗ -
Feb 24, 2022 Feb 28, 2022 PAULS ERIC Senior VP, Sales Neutral 90.0 +12,944 217.36% ✗ -
Feb 24, 2022 Feb 28, 2022 Asbury Valerie L. Director Neutral 90.0 +2,435 100.00% ✗ -
Feb 24, 2022 Feb 28, 2022 Shafer David Brent Director Neutral 90.0 +2,435 100.00% ✗ -
Jan 12, 2022 Shafer David Brent Director Neutral 52.5 - 0.00% ✗ -
Jan 12, 2022 Asbury Valerie L. Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2021 Oct 5, 2021 ROCHE KEVIN H Director Neutral 52.5 - 0.00% ✗ -
Sep 2, 2021 Sep 7, 2021 Moen Brent CFO Sell 46.3 -486 -1.89% ✗ $21.8K
Aug 6, 2021 Aug 9, 2021 REUVERS DANIEL L. CEO Sell 26.3 -1,063 -4.48% ✗ $45.8K